Shelley L Forrest Selected Research

Amyloid (Amyloid Fibrils)

1/2024	Multiple system atrophy with amyloid-β-predominant Alzheimer's disease neuropathologic change.
12/2022	Expanding the spectrum of amyloid-β plaque pathology: the Down syndrome associated 'bird-nest plaque'.
11/2022	Association of glial tau pathology and LATE-NC in the ageing brain.
10/2022	Loss of LAMP5 interneurons drives neuronal network dysfunction in Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shelley L Forrest Research Topics

Disease

5	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 07/2015
4	Tauopathies 01/2024 - 12/2016
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 07/2015
3	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2019 - 12/2016
2	Multiple System Atrophy 01/2024 - 07/2015
2	Parkinson Disease (Parkinson's Disease) 11/2023 - 07/2015
2	Synucleinopathies 11/2023 - 07/2015
2	Proteostasis Deficiencies 11/2023 - 01/2023
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 11/2023 - 01/2023
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 10/2015
2	Frontotemporal Dementia (Semantic Dementia) 01/2019 - 10/2015
1	Cognitive Dysfunction 01/2024
1	Lewy Body Disease (Lewy Body Dementia) 11/2023
1	Corticobasal Degeneration 11/2023
1	Chronic Traumatic Encephalopathy 11/2023
1	Pick Disease of the Brain (Pick's Disease) 11/2023
1	Disease Progression 01/2023
1	Down Syndrome (Down's Syndrome) 12/2022
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 11/2022
1	limbic-predominant age-related TDP-43 encephalopathy 11/2022
1	Encephalitis (Encephalitis, Rasmussen) 10/2021
1	COVID-19 10/2021
1	Parkinsonian Disorders (Parkinsonism) 01/2018
1	Dementia (Dementias) 07/2015
1	Peripheral Nerve Injuries 08/2010
1	Inflammation (Inflammations) 02/2008

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2016
4	Proteins (Proteins, Gene)FDA Link 01/2024 - 07/2015
4	SynucleinsIBA 01/2024 - 07/2015
4	Amyloid (Amyloid Fibrils)IBA 01/2024 - 10/2022
2	Protein AggregatesIBA 11/2023 - 01/2023
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023 - 01/2018
2	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2021 - 10/2015
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 08/2010 - 02/2008
1	Apolipoproteins E (ApoE)IBA 01/2024
1	Peptides (Polypeptides)IBA 01/2024
1	SilverIBA 11/2023
1	tau Proteins (tau Protein)IBA 11/2019
1	Protein Isoforms (Isoforms)IBA 11/2019
1	ProgranulinsIBA 01/2019
1	AntibodiesIBA 07/2015
1	NeurturinIBA 08/2010
1	Nerve Growth Factor (NGF)IBA 02/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2008

Therapy/Procedure

3	Therapeutics 01/2024 - 12/2016
1	Ambulatory Care (Outpatient Care) 01/2024